Jamjoom Pharma began its manufacturing and sales operations in 2000. The company’s main operating production facility is a 46,500-square-meter manufacturing plant in Jeddah with a production capacity of 113 million units per year. In May 2023, the company set the final offer price for its IPO on the Saudi stock exchange at $16 per share to raise $336 million.